Merck Sharp & Dohme Europe Belgium SRL
Companies and groups · United States
In these lists: Biggest budgets, Medicines
- Declared lobbying cost
- €1,750,000 – €1,999,999 Financial year 01/2025-12/2025
- Commission meetings
- 37
- Full-time staff on EU lobbying
- 6.3
- European Parliament access passes
- 14
- Registered since
- 14 May 2010
Public records onlyWhat this means
Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself
Fields of interest
Business and industry, Competition, Consumers, Customs, Digital economy and society, Economy, finance and the euro, Education and training, Employment and social affairs, Environment, Humanitarian aid and civil protection, Institutional affairs, International co-operation and development, Public health, Regional policy, Research and innovation, Single market, Taxation, Trade, Trans-European Networks
Medicines and food topics they name
EU medicines law
EU laws and policies they declare following1
- EU initiatives pertaining to pharmaceutical policy, industrial policy, health policy (both human and animal) and trade policy, eg, Clinical Trials Regulation, Data Protection Regulation, Public Procu…
Meetings with the Commission
Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them